These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 20704266)
1. Dissolution modeling of bead formulations and predictions of bioequivalence for a highly soluble, highly permeable drug. Sperry DC; Thomas SJ; Lobo E Mol Pharm; 2010 Oct; 7(5):1450-7. PubMed ID: 20704266 [TBL] [Abstract][Full Text] [Related]
2. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim. Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464 [TBL] [Abstract][Full Text] [Related]
3. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac. Kambayashi A; Blume H; Dressman J Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057 [TBL] [Abstract][Full Text] [Related]
4. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers. Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557 [TBL] [Abstract][Full Text] [Related]
5. Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans. Shono Y; Jantratid E; Kesisoglou F; Reppas C; Dressman JB Eur J Pharm Biopharm; 2010 Sep; 76(1):95-104. PubMed ID: 20576487 [TBL] [Abstract][Full Text] [Related]
7. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach. Fei Y; Kostewicz ES; Sheu MT; Dressman JB Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116 [TBL] [Abstract][Full Text] [Related]
8. A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study. Kuentz M; Nick S; Parrott N; Röthlisberger D Eur J Pharm Sci; 2006 Jan; 27(1):91-9. PubMed ID: 16219449 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of pantoprazole formulations in different dissolution apparatus using biorelevant medium. de Campos DR; Klein S; Zoller T; Vieria NR; Barros FA; Meurer EC; Coelho EC; Marchioretto MA; Pedrazzoli J Arzneimittelforschung; 2010; 60(1):42-7. PubMed ID: 20184226 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates. Kortejärvi H; Urtti A; Yliperttula M Eur J Pharm Sci; 2007 Feb; 30(2):155-66. PubMed ID: 17187967 [TBL] [Abstract][Full Text] [Related]
11. Differences in the in vitro and in vivo pharmacokinetic profiles of once-daily modified-release methylphenidate formulations in Canada: examination of current bioequivalence criteria. Shram MJ; Quinn AM; Chen N; Faulknor J; Luong D; Sellers EM; Endrenyi L Clin Ther; 2012 May; 34(5):1170-81. PubMed ID: 22512898 [TBL] [Abstract][Full Text] [Related]
12. Bioequivalence evaluation of two brands of lisinopril tablets by in vitro comparative dissolution test and in vivo bioequivalence test. Shin MC; Kim JK; Kim CK Arzneimittelforschung; 2008; 58(1):11-7. PubMed ID: 18368945 [TBL] [Abstract][Full Text] [Related]
13. Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling. Shono Y; Jantratid E; Janssen N; Kesisoglou F; Mao Y; Vertzoni M; Reppas C; Dressman JB Eur J Pharm Biopharm; 2009 Sep; 73(1):107-14. PubMed ID: 19465123 [TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro dissolution and in vivo bioequivalence of two diclofenac enteric coated formulations. Basmenji S; Valizadeh H; Zakeri-Milani P Arzneimittelforschung; 2011; 61(10):566-70. PubMed ID: 22164964 [TBL] [Abstract][Full Text] [Related]
15. A pH-dilution method for estimation of biorelevant drug solubility along the gastrointestinal tract: application to physiologically based pharmacokinetic modeling. Gao Y; Carr RA; Spence JK; Wang WW; Turner TM; Lipari JM; Miller JM Mol Pharm; 2010 Oct; 7(5):1516-26. PubMed ID: 20715778 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the dissolution and pharmacokinetic profiles of two galenical formulations of the endothelin receptor antagonist macitentan. Kummer O; Haschke M; Hammann F; Bodmer M; Bruderer S; Regnault Y; Dingemanse J; Krähenbühl S Eur J Pharm Sci; 2009 Nov; 38(4):384-8. PubMed ID: 19765655 [TBL] [Abstract][Full Text] [Related]
17. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers. Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838 [TBL] [Abstract][Full Text] [Related]
18. Predicting the oral absorption of a poorly soluble, poorly permeable weak base using biorelevant dissolution and transfer model tests coupled with a physiologically based pharmacokinetic model. Wagner C; Jantratid E; Kesisoglou F; Vertzoni M; Reppas C; B Dressman J Eur J Pharm Biopharm; 2012 Sep; 82(1):127-38. PubMed ID: 22652546 [TBL] [Abstract][Full Text] [Related]
19. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers. Ahmad M; Pervaiz F Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997 [TBL] [Abstract][Full Text] [Related]
20. Bioequivalence of a single 10-mg dose of finasteride 5-mg oral disintegrating tablets and standard tablets in healthy adult male Han Chinese volunteers: a randomized sequence, open-label, two-way crossover study. Chen L; Jiang X; Huang L; Lan K; Wang H; Hu L; Ren J; Li X; Zou Q Clin Ther; 2009 Oct; 31(10):2242-8. PubMed ID: 19922895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]